LA JOLLA PHARMACEUTICAL COMPANY ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of LJPC and Encourages Investors to Contact the Firm NEW YORK, July 14, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors...

MERIDIAN BIOSCIENCE ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of VIVO and Encourages Investors to Contact the Firm NEW YORK, July 11, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors...

EPIZYME ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of EPZM and Encourages Investors to Contact the Firm NEW YORK, July 01, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors...

ZENDESK HEALTH ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of ZEN and Encourages Investors to Contact the Firm NEW YORK, June 27, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors...

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Array, ContextLogic, Ubiquiti, and Frequency and Encourages Investors to Contact the Firm NEW YORK, June 23, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...